You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mycobacterium Tuberculosis

Showing 1 - 25 of 1,439
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Latent Tuberculosis Infection Trial (Recombinant Mycobacterium Tuberculosis Fusion Protein, Purified Protein Derivative of

Not yet recruiting
  • Latent Tuberculosis Infection
  • Recombinant Mycobacterium Tuberculosis Fusion Protein
  • Purified Protein Derivative of Tuberculin
  • (no location specified)
Jun 8, 2023

Kit for Diagnosis of Tuberculosis Disease

Not yet recruiting
  • Tuberculosis, Pulmonary
  • +2 more
  • NanoDetect-TB
  • (no location specified)
Jul 31, 2023

Latent Tuberculosis Infection Trial (Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected)

Not yet recruiting
  • Latent Tuberculosis Infection
  • Recombinant Mycobacterium tuberculosis fusion protein for injection
  • TB-PPD was injected
  • (no location specified)
Feb 16, 2023

Latent Tuberculosis Infection Trial (Mycobacterium Vaccae for Injection)

Not yet recruiting
  • Latent Tuberculosis Infection
  • Mycobacterium Vaccae for Injection
  • (no location specified)
Dec 23, 2022

Time-to-Detection in Culture of Mycobacterium Tuberculosis

Completed
  • Pulmonary Tuberculoses
  • No intervention
  • Nice, France
    Nice University Hospital
Oct 4, 2022

Tuberculosis, Multidrug Resistant Tuberculosis Trial in Paris (Tedizolid arm (SIVEXTRO®), Linezolid arm (ZYVOXID®), Standard

Not yet recruiting
  • Tuberculosis
  • Multidrug Resistant Tuberculosis
  • Tedizolid arm (SIVEXTRO®)
  • +2 more
  • Paris, France
    Bacteriology department- Hôpital Saint-Antoine
Sep 6, 2022

MTB cfDNA Levels in TBP

Not yet recruiting
  • Tuberculosis, Pleural
  • Mycobacterium tuberculosis (MTB) cell-free DNA (cf-DNA)
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
May 25, 2022

Tuberculosis Trial in Changsha (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), High-dose freeze-dried

Recruiting
  • Tuberculosis
  • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
  • +3 more
  • Changsha, Hunan, China
    Hunan Provincial Center for Disease Control and Prevention
Sep 2, 2022

Latent Tuberculosis, Persistent Infection, Mycobacterium Tuberculosis Trial in Malmö

Recruiting
  • Latent Tuberculosis
  • +2 more
    • Malmö, Skåne, Sweden
      Skåne University Hospital
    Nov 10, 2022

    Multiplex PCR -Microarray-based Assay in Detection of

    Completed
    • Tuberculosis
    • Non-Tuberculous Mycobacterial Pneumonia
    • VereMTB
    • Sha Tin, Hong Kong
      Prince of Wales Hospital
    Aug 7, 2022

    Human Immunodeficiency Virus Trial in South Africa (M72/AS01E Mycobacterium tuberculosis vaccine, Placebo)

    Active, not recruiting
    • Human Immunodeficiency Virus
    • M72/AS01E Mycobacterium tuberculosis vaccine
    • Placebo
    • Johannesburg, Gauteng, South Africa
    • +5 more
    Feb 26, 2022

    Tuberculosis Trial in Wuhan (Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02), Low-dose adjuvant for

    Completed
    • Tuberculosis
    • Low-dose freeze-dried recombinant tuberculosis vaccine (AEC / BC02)
    • +2 more
    • Wuhan, Hubei, China
      Wuhan Infectious Disease Hospital
    Sep 2, 2022

    Bone Resistant Tuberculosis

    Completed
    • Bone and Osteoarticular Infection Due to MDR M. Tuberculosis Strains
    • Descriptive retrospective study
    • Paris, France
      Pitié Salpêtrière Hospital
    May 9, 2022

    Mycobacterial and Opportunistic Infections in HIV-Negative Thai

    Active, not recruiting
    • Non-Tuberculous Mycobacteria
    • +2 more
      • Taiwan, China
        National Taiwan University
      Aug 18, 2022

      Tuberculosis Trial in Shanghai (Placebo, Low dose adjuvant, High dose adjuvant)

      Completed
      • Tuberculosis
      • Placebo
      • +4 more
      • Shanghai, Shanghai, China
        Shanghai Public Health clinical Center
      Mar 9, 2022

      Tuberculosis Trial in Busan (Thin bronchoscope and VBN)

      Completed
      • Tuberculosis
      • Thin bronchoscope and VBN
      • Busan, Korea, Republic of
        Pusan National University Hospital
      Apr 19, 2022

      Mycobacterium Tuberculosis Infection Trial in Worldwide (VPM1002, BCG SII)

      Active, not recruiting
      • Mycobacterium Tuberculosis Infection
      • VPM1002
      • BCG SII
      • Lambaréné, Gabon
      • +11 more
      Dec 19, 2022

      Tuberculosis, HIV I Infection, Sepsis Trial in Sanya Juu, Mbarara (Immediate anti-TB therapy, Sepsis-specific dose anti-TB

      Recruiting
      • Tuberculosis
      • +2 more
      • Immediate anti-TB therapy
      • Sepsis-specific dose anti-TB therapy
      • Sanya Juu, Tanzania
      • +1 more
      Dec 10, 2021

      Malnutrition, Diabetes Mellitus, and Helminth Infections on

      Active, not recruiting
      • Mycobacterium Tuberculosis
      • +4 more
        • Chennai, India
          National Institute for Research In Tuberculosis, International C
        Jul 28, 2022

        Tuberculosis, Pulmonary, Mycobacterium Tuberculosis Infection Trial in Kampala (Active TB case finding with linkage to

        Recruiting
        • Tuberculosis, Pulmonary
        • Mycobacterium Tuberculosis Infection
        • Active TB case finding with linkage to preventive therapy (ACF/TPT)
        • Kampala, Uganda
          Walimu
        Jun 8, 2022

        Tuberculosis Trial in Worldwide (M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine, Placebo)

        Not yet recruiting
        • Tuberculosis
        • M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine
        • Placebo
        • Bandung, Indonesia
        • +59 more
        Sep 25, 2023

        Gene Expression Profiles in Spinal Tuberculosis.

        Recruiting
        • Tuberculosis, Spinal
        • +13 more
          • Cape Town, Western Cape, South Africa
            Groote Schuur Hospital
          Nov 7, 2022

          Tuberculosis Trial in South Africa (BCG vaccine SSI, Placebo)

          Active, not recruiting
          • Tuberculosis
          • BCG vaccine SSI
          • Placebo
          • Klipfontein, Cape Town, South Africa
          • +4 more
          Aug 10, 2021

          Serological Test for the Diagnosis of TB

          Terminated
          • Active Tuberculosis
          • No intervention
          • Montpellier, France
            University Hospital Montpellier Department of microbiology
          Dec 9, 2021

          Tuberculosis Trial in Kisumu (Isoniazid)

          Completed
          Has Results
          • Tuberculosis
          • Kisumu, Kenya
            Kisumu County Hospital
          May 15, 2021